Columbus A/S
Columbus – Weekly report on share buyback
Columbus – Weekly report on share buyback
Company announcement no. 22/2025
Transactions in the period 8 September 2025 to 12 September 2025
On 30 June 2025, Columbus A/S announced a share buyback programme under which the company will repurchase shares for up to DKK 16m during the period from 30 June 2025 to 11 March 2026, both dates included, as outlined in company announcement no. 8/2025.
The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.
The following transactions were made under the share buyback programme in the period 8 September 2025 to 12 September 2025:
| Number of shares bought | Average purchase price (DKK) | Transaction value (DKK) | |
| Accumulated, last announcement | 615,047 | 10.08 | 6,197,537.75 |
| 8 September 2025 | 4,545 | 10.24 | 46,518.53 |
| 9 September 2025 | 11,000 | 10.37 | 114,121.70 |
| 10 September 2025 | 11,000 | 10.35 | 113,850.00 |
| 11 September 2025 | 8,349 | 10.37 | 86,605.85 |
| 12 September 2025 | 12,000 | 10.22 | 122,592.00 |
| Total, 8 September 2025 to 12 September 2025 | 46,894 | 10.31 | 483,688.08 |
| Total accumulated under the programme | 661,941 | 10.09 | 6,681,225.82 |
With the transactions stated above, Columbus A/S holds a total of 661,941 own shares, corresponding to 0.51% of the Company’s share capital.
Ib Kunøe Søren Krogh Knudsen
Chairman of the Board CEO & President
For further information, please contact: CEO & President, Søren Krogh Knudsen, +45 70 20 50 00 |
Attachments
- SE_22_2025_Weekly_report_on_share_buyback
- Columbus - Share buyback transactions 8 September 2025 - 12 September 2025
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Atico Mining Corporation17.9.2025 22:30:00 CEST | Press release
Atico Signs the Investment Protection Agreement with Government of Ecuador for its La Plata Project
Frontline plc.17.9.2025 22:06:51 CEST | Press release
FRO – Filing of Half Yearly Report
VCI Global Limited17.9.2025 21:00:00 CEST | Press release
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom